# Home Transcranial Direct Current Stimulation (tDCS) to Enhance Functional Recovery

> **NCT07091396** · NA · ENROLLING_BY_INVITATION · sponsor: **Mayo Clinic** · enrollment: 55 (estimated)

## Conditions studied

- Stroke
- Neurodegeneration
- Brain Tumor

## Interventions

- **DEVICE:** Soterix® tDCS - Home treatment
- **BEHAVIORAL:** Cognitive-linguistic therapy
- **DEVICE:** Soterix® tDCS - Lab treatment

## Key facts

- **NCT ID:** NCT07091396
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-01-16
- **Primary completion:** 2030-12
- **Final completion:** 2031-12
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07091396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07091396, "Home Transcranial Direct Current Stimulation (tDCS) to Enhance Functional Recovery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07091396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*